Cite
HARVARD Citation
Louis, E. et al. (n.d.). S713 Induction and Maintenance Treatment with Risankizumab Leads to Symptomatic Relief in Patients With Moderate to Severe Crohn's Disease. American journal of gastroenterology. pp. e496-e497. [Online].